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to the dialysate/volume method to estimate eKt/V and SRIImprecision of the hemodialysis dose when measured directly
during two to five subsequent dialyses per patient (comparisonfrom urea removal.
dialyses). The accuracy and precision of these estimates wereBackground. The postdialysis blood urea nitrogen (BUN;
assessed by comparing them with eKt/V and SRI derived fromCt) is a pivotal parameter for assessing hemodialysis adequacy
a direct measurement of Ceq drawn 30 minutes after dialysisby conventional blood-side methods, but Ct is relatively unsta-
(reference method), from mathematical curve-fitting of se-ble because of hemodialysis-induced disequilibrium. The un-
quential dialysate urea concentrations (dialysate curve-fitcertainty associated with this method is potentially reduced or
method), and from another blood-side method that estimateseliminated by measuring urea removed on the dialysate side,
eKt/V from single pool Kt/V and the fractional rate of solutea more direct approach that can determine adequacy from the
removal (rate method): eKt/V 5 spKt/V 2 0.6 · K/V 1 0.03.fraction of urea removed and by substituting an estimate of
the equilibrated postdialysis BUN (Ceq) for Ct. For a patient Results. During 128 comparison dialyses, median absolute
with a known urea volume (V), Ceq, the equilibrated Kt/V errors for calculated eKt/V compared with the reference method
(eKt/V), and the solute removal index (SRI) can be calculated were 0.169, 0.061, and 0.071 for the dialysate/volume method, the
from the predialysis BUN (C0), total urea nitrogen removed rate method, and the dialysate curve-fitting method, respectively.
(A), and V from simple mass balance calculations (dialysate/ The corresponding correlation coefficients were 0.47, 0.88, and
volume method). However, a theoretical error analysis showed 0.81. For SRI, median absolute errors were 0.044, 0.018, and
that relatively small errors in A, C0, or V are magnified when 0.027, and the correlation coefficients were 0.54, 0.85, and 0.74
SRI or eKt/V is calculated using this method, especially at for the three methods.
higher eKt/V values (for example, if eKt/V 5 1.4 per dialysis, Conclusions. The precision of eKt/V and SRI measurements
a 7% dialysate collection error causes a 20% error in eKt/V). was significantly lower for the dialysate/volume method com-
Methods. During three to four baseline dialyses in each of pared with the blood-side methods. Inclusion of the dialysate
39 patients enrolled in the pilot phase of the HEMO Study, curve analysis provided by the Biostatt restored precision to
“A” was measured using an instrument that sampled dialysate the dialysate method to a level comparable to that of the blood-
frequently (Biostatt), and V was calculated from A, C0, and side methods. New techniques employing dialysate urea analy-
Ceq (median CV for V 5 5.6%). The mean V was then applied sis should include a concentration profile to avoid these inher-
ent methodological errors and assure the accuracy of eKt/V
and SRI.
1 The institutions and investigators who participated in the Hemodialy-
sis (HEMO) Pilot Study are: Garabed Eknoyan (Baylor College of
Medicine, Houston, Texas), Joel Kopple (Harbor/UCLA, Los Angeles,
The most commonly used methods for quantitatingCalifornia), Andrew Levey (New England Medical Center, Boston,
Massachusetts), Nathan Levin (Beth Israel Medical Center, Boston, hemodialysis are based on measurement of the dialysis-
Massachusetts), Shaul Massry (University of Southern California School induced fall in serum urea concentration (BUN) [1–5].
of Medicine, Los Angeles, California), Gerald Schulman (Vanderbilt
Because the fall in BUN is an indirect measure of theUniversity Medical Center, Nashville, Tennessee), Gerald Beck (Data
Coordinating Center, Cleveland Clinic Foundation, Cleveland, Ohio), primary effect of dialysis, the removal of solute, an alter-
and John Kusek (NIDDK Project Officer, Bethesda, Maryland). native, more direct measurement of urea loss on the
dialysate side, has been proposed [6–9]. Dialysate-basedKey words: direct dialysate quantification, urea kinetic modeling, error
analysis, dialysate-side modeling, hemodialysis adequacy. methods may also be used to measure the dialyzer urea
clearance, independent of blood flow measurements, andReceived for publication March 31, 1998
the patient’s true urea distribution volume (V). The lat-and in revised form August 24, 1998
Accepted for publication August 24, 1998 ter coincides with total body water, a relatively constant
physiologic parameter. Development of an instrument 1999 by the International Society of Nephrology
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(Biostat 1000t; Baxter Healthcare Corporation, McGaw index (SRI), respectively. The SRI is an estimate of the
fraction of urea removed during dialysis, which, unlikePark, IL, USA) to facilitate on-line measurement of rela-
tively low dialysate urea concentrations sparked new URR, also takes into account urea generation and ultra-
filtration [23].interest is this approach [10, 11]. The new dialysate meth-
odology allows more accurate measurement of urea re- In principle, if urea can be measured in the dialysate,
the calculation of the dialysis dose is more straightfor-moval by eliminating problems with bacterial contamina-
tion and other sources of error that confounded previous ward, is constrained by fewer assumptions than blood-
based methods, and does not require routine measure-dialysate methods.
In current practice, hemodialysis dosage is often ex- ment of the postdialysis BUN. This direct quantitation
approach compares the amount of urea removed duringpressed as the urea reduction ratio (URR) or as Kt/V
derived from single pool mathematical modeling of urea dialysis with the amount of urea present in the patient
at the start of dialysis. In the absence of urea generationmass balance (spKt/V). The latter is a measure of dia-
lyzer clearance expressed per dialysis (instead of per and fluid volume changes:
minute) and expressed as a fraction of the urea distribu-
tion volume (instead of body surface area). On the blood V 5 A/(C0 2 Ceq) (Eq.1)
side, both URR and spKt/V are determined primarily
from the fractional reduction in BUN during dialysis, Ceq 5 C0 2 A/V (Eq.2)
but spKt/V also includes the effects of urea generation
and ultrafiltration [12]. Dependence on the postdialysis Because it was envisioned as a possible future standard
for quantitating hemodialysis, this approach was in-BUN measurement is often cited as a weakness of these
current blood-side techniques [11, 13]. The postdialysis cluded in the pilot phase of the HEMO Study, a prospec-
tive multicenter clinical trial of the effects of dialysisBUN is difficult to measure because precautions must
be taken to avoid distortion caused by vascular access dose and membrane flux on survival [24]. In the pilot
study, each patient’s V was first estimated from therecirculation and by dilution of the sample with intrave-
nous fluids (saline, blood, and other solutions) often amount of urea removed in the dialysate and the net fall
in BUN (to equilibrium) during each of three baselinegiven near the end of the treatment. In addition, cardio-
pulmonary and venovenous recirculation during dialysis treatments. For subsequent modeled dialyses, the pa-
tient’s predialysis urea content was calculated as theinduce a urea concentration disequilibrium between the
blood entering the dialyzer and the patient. This urea product of this estimate of V and the predialysis BUN.
The SRI and eKt/V for these dialyses were then calcu-gradient quickly reverses beginning approximately 10
to 20 seconds after slowing or stopping dialysis and is lated from the patient’s estimated predialysis urea con-
tent and the measured loss of urea in the dialysate. Thisaccompanied by a rapid rise in the BUN [14]. The insta-
bility of the postdialysis BUN caused by all of these technique is subsequently referred to as the “dialysate/
volume method.”conditions necessitates precise timing of the sampling,
within a short time window (measured in seconds), to The HEMO pilot study provided an opportunity to
assess the performance of several blood-side or dialysate-avoid errors in the modeled parameters [15, 16].
Even when these sources of error are eliminated, side methods to estimate eKt/V and SRI. To provide a
reference for comparison, the pilot study protocol in-blood-side methods routinely overestimate the effective
dialysis dose because the BUN continues to rebound, cluded a blood sample obtained 30 minutes after termi-
nation of dialysis. The SRI and eKt/V calculated usingalthough more slowly, for 20 to 60 minutes following
dialysis. Rebound is caused by re-equilibration of multi- this value were used as reference standards to which
results of the dialysate/volume method and several alter-ple urea concentration gradients that develop within the
patient during dialysis when solute removal is relatively native methods that do not require delayed postdialysis
sampling were compared. The objective of this reportrapid [17–19]. Thus, accurate blood-side assessment of
the effective dialysis dose requires an estimation of the is to evaluate the performance of the dialysate/volume
method in comparison with these alternative blood-sidepostdialysis BUN after urea concentrations have fully
equilibrated within the patient. This can be accomplished and dialysate-side methods.
Comparisons of the agreement of kinetic parameterseither by directly measuring the BUN at least 30 minutes
after dialysis, at substantial inconvenience to the patient estimated by the different methods with corresponding
parameters calculated from the 30-minute postdialysisand staff, or by predicting the equilibrated postrebound
BUN assuming a specific mathematical model of re- BUN are not entirely conclusive because of error cou-
pling among the blood-side estimates that use commonbound [20–22]. When the equilibrated postdialysis BUN
is used in place of the immediate postdialysis BUN to BUN measurements. When analyzing errors, one must
consider the possibility that the level of agreement ob-calculate spKt/V and URR, the analogous results are
the equilibrated Kt/V (eKt/V) and the solute removal served among the blood-side estimates could be en-
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hanced by the commonality of BUN measurements that quent two weeks. This report does not separate patients
based on their randomized target eKt/V, but insteadenter into each estimate. To avoid this pitfall, we in-
cluded analyses comparing the dialysate/volume and examines the aggregate of delivered eKt/V values mea-
sured by the four methods described later here. Analysesblood-based techniques to a recently developed dialysate
technique that is based on mathematical curve fitting of the effects of randomization on dialysis dose are de-
scribed elsewhere [25].of dialysate urea concentrations measured throughout
dialysis [10]. Dialysate urea concentrations were mea-
Proceduressured on-line in near real time by an analyzer that was
different from the analyzer used to measure BUN, thus For all modeled dialyses, blood samples for BUN de-
termination were drawn before starting dialysis (C0),reducing the likelihood that errors would be coupled to
errors in blood-side measurements. after reducing blood flow to 100 to 120 ml/min for 10
seconds after terminating dialysis (Ct), and 30 minutesWe also conducted a statistical error analysis to com-
pare the within-patient variability of eKt/V and SRI, after dialysis (C30). All BUN concentrations were mea-
sured at a central biochemistry laboratory (Spectra Lab-calculated by the dialysate/volume method, with the
within-patient variability of eKt/V and SRI calculated oratories, Inc., Fremont, CA, USA). For external quality
control, 52 sets of blood samples were obtained predial-by the blood-side methods. This analysis compared the
effects of different sources of measurement error among ysis (C0), after 70 minutes of dialysis, and at the end of
dialysis (Ct). Each of these samples was split into twothe methods without the confounding effects of error
coupling. aliquots by the clinical center and was shipped on differ-
ent days to the central biochemistry laboratory for
blinded analysis.
METHODS
An instrument designed to measure dialysate urea ni-
Study design trogen concentrations at frequent intervals (Biostat
1000t) was attached to the effluent dialysate line duringData were collected during the pilot phase of the
HEMO Study, a large multicenter interventional study all studied dialyses [10, 11]. Dialysate urea concentration
was measured at five-minute intervals during the first 30of the effect of hemodialysis dose and membrane perme-
ability on patient morbidity and mortality over a pro- minutes of dialysis and at 10-minute intervals thereafter.
Total dialysate urea nitrogen (A) was computed as thelonged time [24]. For the pilot phase that was designed
to examine the feasibility of conducting the full-scale product of the dialysate flow, which was assumed con-
stant, and the integrated dialysate concentration profile.study, patients maintained for at least six months on
hemodialysis three times a week were selected from four An estimate of the predialysis BUN was obtained from
a dialysate sample that was equilibrated with the bloodclinical centers: Beth Israel Medical Center, New York,
New York; Harbor-UCLA Medical Center, Los An- at the start of dialysis.
Measuring the amount of urea in the dialysate maygeles, California; New England Medical Center/St. Eliza-
beth’s Hospital, Boston, Massachusetts; and Vanderbilt also incur errors, but the errors are easier to avoid. Po-
tential problems with collecting, mixing, and storing largeUniversity Medical Center, Nashville, Tennessee, USA.
Qualified patients who consented to enroll were studied amounts of dialysate; loss of dialysate urea from bacterial
contamination; and the problem with measuring typicallyduring three phases while undergoing hemodialysis three
times weekly. low dialysate urea concentrations have been circum-
vented by the Biostat 1000t, an instrument that samplesPhase I. During a baseline observational period that
lasted approximately three weeks, potential study parti- dialysate and measures urea concentrations on-line [11,
26]. Urea concentrations in the dialysate are based oncipants were treated with their usual dialysis prescrip-
tion. Urea kinetics were modeled, and dosage parame- a coupled urease/conductivity method optimized for the
low urea concentrations found in dialysate, especiallyters were calculated from BUN values obtained during
and 30 minutes following three to four dialyses in each toward the end of the dialysis treatment [10]. Frequent
measurements of dialysate urea concentration by thispatient.
Phase II. During the subsequent two weeks, patients instrument, especially early in dialysis when a propor-
tionately larger amount of urea is removed and concen-were treated with a dialysis prescription that targeted
eKt/V at 1.40 per dialysis. Urea kinetics were modeled trations are more critical, increase the precision and ac-
curacy of total urea removal. The instrument alsoduring two to four dialyses in this phase.
Phase III. Patients who successfully achieved the min- includes a program for analyzing the dialysate concentra-
tion/time curve used for the curve-fitting method de-imum target eKt/V during phase II and who satisfied
other study eligibility criteria were randomized to a tar- scribed earlier here. For the dialysate/volume method
used in this study, the curve fitting and other featuresget eKt/V of 1.00 or 1.40 per dialysis three times weekly.
Each patient had two modeled dialyses during the subse- of the Biostatt were ignored, and the instrument was
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used solely to calculate the amount of urea removed values for cardiac output (CO) and access blood flow
(Qac) [14]:during each dialysis from integration of the periodic
5- and 10-minute dialysate sample concentrations and
Fcp 5 1/[1 1 Kac/(CO 2 Qac)] (Eq.3)measured dialysate flow rates.
Patients where Kac is the access clearance. Qac was assumed to be
800 ml/min, and CO was estimated assuming a meanAs reported previously, complete kinetic modeling
cardiac index of 3.0 per m2 body surface area.data were obtained from 295 dialyses in 49 pilot study
The reference method depends heavily on C30, but itparticipants [25]. In this report, analyses were restricted
is important to add that C30 is not simply used as ato 39 of these patients who had complete data for at
substitute for Ceq. The latter is determined from a formalleast three phase I and at least one phase II or phase
two-compartment model of urea kinetics applied individ-III modeled dialyses. Although 8 of these 39 patients had
ually to each patient.four phase I modeled dialyses, analyses were restricted to
A value for eKt/V was then computed by applying athe first three phase I modeled dialyses for consistency.
single-compartment, variable-volume model of hemodi-We also excluded one modeled dialysis in phase II for
alysis urea kinetics to C0, Ceq, the intradialysis weightwhich the dialysate/volume method produced a negative
loss, and the estimated total V [3, 28].estimate for the equilibrated postdialysis BUN. With
The solute removal index was computed as followsthese restrictions, this report is based on 117 modeled
[23]:dialyses in 39 patients during phase I, 72 modeled dialy-
ses in the same 39 patients during phase II, and 56 mod-
eled dialyses in 30 of these patients who were random- SRI 5
C0[V 1 Qf · Td] 2 V · Ceq 1 G · Td
C0[V 1 Qf · Td]
(Eq.4)
ized in phase III. The median age of the 39 patients
considered in the report was 61.8 (range 29.0 to 75.5)
years. Twenty-four were males, 21 were African Ameri- where Qf is the rate of weight lost during dialysis, and
Td is the treatment time. V is the patient’s total V postdi-can, and 20 were diabetic.
alysis, and G is an estimate of the urea generation rate;
Calculations of eKt/V and SRI both were determined from the two-compartment model
described earlier here.Two blood-side and two dialysate-side methods were
The rate adjustment method. This method assumescompared. For each of the blood-side methods and for
that the rebound in BUN after completion of dialysis isthe dialysate/volume method, we first estimated the
related to the fractional rate of urea removal (Kd/V)equilibrated postdialysis BUN concentration (Ceq).
during dialysis [22]:Given Ceq for a particular method, we then computed
the corresponding eKt/V from C0, Ceq, and an estimate of
urea volume using a single compartment variable volume eKt/V 5 spKt/V 2 0.6 · Kd/V 1 0.03
(Kd is expressed as ml/hr)
(Eq.5)
model of urea kinetics [1, 3, 27]. For each of the four
methods, the SRI [23] was computed from C0, Ceq, the
change in patient weight during dialysis, and an estimate Here, spKt/V is the estimate of Kt/V obtained from
of the equilibrated urea generation rate. These calcula- single-compartment urea kinetic modeling using C0 and
tions are described in more detail later here. the measured postdialysis Ct [3, 27]. To calculate SRI by
this method, we first obtained an estimate of the whole
Blood-side methods body clearance (Kwb):
The reference method. A two-compartment, variable-
volume, diffusion model of hemodialysis urea kinetics Kwb 5 eKt/V · V/Td (Eq.6)
was first fit to C0, the adjusted Ct, and the 30-minute
postdialysis BUN (C30) using the theoretical dialyzer Kwb and V were used to calculate Ceq from the single-
clearance (Kd). This model provided estimates of the compartment, variable-volume model. SRI was then cal-
intercompartment transfer coefficient (Kc) and the total culated using equation 4.
urea volume (V), which were then used to estimate the
Dialysate-side methodsfully equilibrated BUN (Ceq) after correction for postdi-
alysis urea generation. Before applying the model, a The dialysate curve-fit method. The profile of dialysate
slight upward adjustment was made in the measured concentration versus elapsed time obtained from the Bi-
postdialysis BUN (Ct) to account for cardiopulmonary ostatt was fitted to a double exponential curve by a
recirculation. The adjusted Ct was defined as Ct/Fcp; the previously described technique [10, 11]. The parameters
that described these curves were used to compute theadjustment factor (Fcp) was calculated assuming average
Depner et al: Imprecision of the hemodialysis dose 639
Table 1. Patient characteristics (mean 6 sd)
Phase II (pre- Phase III (post-
Phase I randomization, target randomization target
Factor (original prescription) eKt/V 5 1.4/dialysis) eKt/V 5 1.0 or 1.4/dialysis)
Number of patients 39 39 30
Postdialysis weight kg 70.5615.6 70.2615.3 70.7613.5
Watson V Liter 36.667.1 36.667.1 36.866.6
|Change| in Watson V from phase I liter — 20.160.4 20.160.4
Treatment time min 208627 220631 219634
Dialyzer clearance ml/min 247629 275629 234633
eKt/V 1.2760.20 1.4160.24 1.3160.24
SRI 0.7260.06 0.7660.08 0.7360.06
patient’s effective or whole-body urea clearance (Kwb), sate/volume method by comparing estimates of eKt/V
and SRI calculated by the dialysate/volume method tothe patient’s total urea V, the eKt/V, and SRI. In 29 of the
modeled dialyses considered in this report, a predialysis corresponding estimates obtained from the reference
method (30-minute rebound) and the dialysate curve-fitequilibrated dialysate sample, which is normally used by
the Biostat to estimate the predialysis BUN, was not method in each patient during the 128 modeled dialyses
of phases II and III. Comparisons included the median Dobtained. In its place, we used the measured predialysis
BUN. The estimated predialysis BUN is not used by the to assess systematic bias between methods, the Pearson
correlation (Pearson R) to assess linear association, theBiostat for determining either eKt/V or the total urea
removed, but does have a small effect on the Biostat Spearman correlation (Spearman R) to assess general
monotonic association, and the median absolute D andestimate of SRI.
The dialysate/volume method. The dialysate/volume concordance correlation coefficient [30] to assess the
agreement between methods. The concordance correla-method comprised two stages. In the first stage, which
included the three modeled dialyses during phase I of tion approaches a value of one if there is perfect agree-
ment between methods.the baseline period, the patient’s postdialysis V was esti-
mated at each modeled dialysis by the following: The level of agreement within patients for the dialysate/
volume method was compared with the agreement among
the blood and dialysate methods. The bootstrap methodV 5 [A 2 Td · (G 1 Qf · C0)]/(C0 2 Ceq) (Eq.7)
[31] with 1,200 independent bootstrap samples was used
to determine approximate P values for these comparisons.where C0 is the predialysis BUN, Ceq is the equilibrated
BUN from the observed 30-minute rebound method (see To account for multiple dialysis modelings for each pa-
tient, the bootstrap resampling was done on a patientThe Reference Method section), G is the equilibrated
urea nitrogen generation rate, Td is the treatment time, basis rather than an individual dialysis treatment basis.
and Qf is the ultrafiltration rate. The estimates of V from
Error analysisthe three modeled dialyses in phase I were averaged to
A statistical error analysis is used to describe the effectobtain a mean V (Vm) for each patient. In subsequent
of errors in measurements of BUN and total urea re-modeled dialyses during phases II and III of the pilot
moval on the calculated values of SRI and eKt/V ob-study, the amount of urea removed and the predialysis
tained by the different methods. To simplify the presen-BUN from the current modeled dialysis were used along
tation, we ignored ultrafiltration and intradialysis ureawith the previously obtained Vm to estimate Ceq based
generation in the error analysis. Then SRI by the dialy-on the following rearrangement of Equation 7:
sate/volume method reduces to:
Ceq 5 C0 2 [A 2 Td · (G 1 Qf · C0)]/Vm (Eq.8)
SRIVol 5
A
C0 · Vm
5 1 2 1(C0 2 A/VmC0 2 (Eq.9)Given Ceq, eKt/V and SRI were computed as described
earlier here for the other methods.
whereas SRI from a blood-based method is:To detect possible confounding effects of longitudinal
changes in weight, the anthropometric volume was also
calculated for each modeled dialysis (Table 1) [29]. SRIblood 5 1 2 1Ceq(blood)C0 2 (Eq.10)
Statistical methods
Assessment of the agreement between estimates of SRI where Ceq(blood) is the estimated equilibrated BUN for
the blood-based method under consideration. Under thisand eKt/V. We assessed the performance of the dialy-
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simplification, the equilibrated Kt/V values associated different methods are therefore given in terms of SRI
only.with the dialysate/volume and blood-based methods are
2ln(1 2 SRIVol) and 2ln(1 2 SRIblood), respectively.
Estimation of coefficients of variation
Errors in SRI The coefficients of variation in the statistical error
analysis were estimated using the bias-corrected maxi-As shown in Appendix B, the coefficient of variation
mum likelihood method described by Connett and Lee(CV denoted by t) of SRI that is due to measurement
[32]. The CVs for C0 and Ct were estimated by applyingerror in the dialysate/volume method is approximated
this method to the 52 quality control specimens submit-by the following:
ted to the clinical laboratory as split samples (see Proce-
dures section). The CV of V was similarly estimatedt(SRIVol) > √t2 (A) 1 t2(C0) 1 t2 (V)/N (Eq.11) from the values of V determined by equation 7 for the
three modeled dialyses during phase I.
where t2(A) and t2(C0) are the squared CVs of the esti-
mates of total urea removal and the predialysis BUN
RESULTSfor the current treatment session, t2(V) is the squared
CV of the estimates of V from equation 7 during the Patient characteristics
prior modeled dialyses, and N is the number of prior Dialysis outcome data for the 39 patients included in
dialyses used in computing the average volume (Vm). In this study are summarized in Table 1, including the initial
this study, N 5 3 for each patient. phase I dialyses while the patients remained on their
The CV of SRI from blood-side methods is approxi- original prescriptions, phase II (prescribed eKt/V 5 1.4),
mated by the following: and phase III following randomization. Dialyzer clear-
ance was measured on the blood side. During phase
I, the coefficients of variation of V determined fromt(SRIblood) >
Ceq(blood)
C0 2 Ceq(blood)
3
equation 7 ranged from 1.1% to 34.2%, with a median
of 5.6%, and 25th and 75th percentiles of 3.2% and√t2(C0) 1 t2(Ceq(blood)) 2 2r · t(C0) · t(Ceq(blood)) 10.9%, respectively. The bias-corrected maximum likeli-
(Eq.12) hood estimate of the parameter t(V) considered in the
statistical error analyses was 11.0%. The lower value of
the median CV compared with the bias-corrected esti-where Ceq(blood) is the estimated equilibrated BUN from
mate is expected, as the median CV has a substantialthe blood-side method and r denotes the correlation
negative bias as an estimate of t(V) when the numbercoefficient of the errors in C0 and Ceq(blood).
of observations per patient is small, as is the case here
Errors in eKt/V (N 5 3 per patient).
We show in Appendix B that the CV of measured
Comparison of agreement among estimates of SRI
eKt/V for a patient dialyzed with a given SRI and and eKt/V
eKt/V is related to the CV for the measured SRI by the
The agreement among the estimates of SRI from theapproximation:
three blood-side and dialysate curve-fit methods is sum-
marized in the top three panels of Figure 1 and in the
t(eKt/VVol) >
SRI
(eKt/V) · (1 2 SRI)
· t(SRI) (Eq.13) top three rows of Table 2. The agreement of the SRI
from the dialysate/volume method with the SRIs from
these three methods is summarized in the bottom three
Equation 13 follows from the approximate logarithmic panels of Figure 1 and in the bottom three rows of Table
relationship between eKt/V and SRI and holds regard- 2. Each of the four measures, median |D|, Pearson R,
less of what method is used to estimate SRI and eKt/V. Spearman R, and the concordance correlation, indicate a
Equations A-1 and A-2 of Appendix A give explicit poorer agreement between the dialysate/volume method
expressions for the CV of eKt/V for the dialysate/volume and each of the three blood-side and dialysate curve-fit
method. Equation 13 shows that the CVs for eKt/V and methods than among the three blood-side and dialysate
SRI calculated by a particular method at a particular curve-fit methods themselves.
dialysis dose are directly related by the factor SRI/[eKt/ Figure 2 and Table 3 show a similar analysis and the
V · (1 2 SRI)]. Hence, a method that produces a more level of agreement among each of the methods for esti-
(or less) reliable estimate of SRI will also tend to produce mating eKt/V. Here too, the median |D|, Pearson R,
a more (or less) reliable estimate of eKt/V. To simplify Spearman R, and the concordance correlation indicate
a poorer agreement of the dialysate/volume method withthe presentation, comparisons of the precision of the
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Fig. 1. Each plot shows the solute removal index (SRI) from 128 modeled dialyses in phases II and III of the HEMO pilot study. Methods for
determining SRI are shown on the x-axis and y-axis of each plot. “Blood Side, 30 Min Post” is the reference method based on the 30-minute
postdialysis BUN. “Blood Side Rate” is the method derived from the spKt/V and the rate equation. “Dialysate curve fit” is the method based on
mathematical fitting of the dialysate concentrations. The three bottom panels show the correlation of the dialysate/volume method with each of
these three methods (Table 2). Rp is the Pearson correlation coefficient. Med |D| is the median absolute value of the deviation.
Table 2. Comparisons of the solute removal index (SRI) derived from different methods
Median Median Spearman Pearson Concordance
Methods compareda D |D| R R R
Blood-side rate equation vs. blood-side reference 20.009 0.018 0.87 0.85 0.84
Dialysate curve fit vs. blood-side reference 20.011 0.027 0.81 0.74 0.74
Dialysate curve fit vs. blood-side rate equation 20.003 0.020 0.86 0.82 0.81
Dialysate/volume vs. blood-side reference 10.002 0.044 0.58 0.54 0.53
Dialysate/volume vs. blood-side rate equation 10.008 0.035 0.60 0.58 0.56
Dialysate/volume vs. dialysate curve fit 10.015 0.050 0.50 0.47 0.46
Data were obtained from 128 Phase II and Phase III modeled dialyses.
a For each of the correlation measures, Spearman R, Pearson R, and Concordance R, the agreement among the two blood-side methods and the dialysate-side
curve fit method (top three rows) was significantly better (P , 0.05) than the agreement of the dialysate/volume method with each of the other three methods
(bottom three rows). For median |D|, the agreement of the blood-side rate equation with both the blood-side reference (first row) and the dialysate curve fit (third
row) were significantly better (P , 0.05) than the agreement of the dialysate/volume method with each of the other three methods (bottom three rows). The
agreement of median |D| between the dialysate curve fit and blood side reference (second row) was also significantly better than the agreement of the dialysate/
volume with both the dialysate curve fit and the blood-side rate equation (P , 0.05), but was not significantly better than the agreement of the dialysate/volume
method with the blood-side standard (P 5 0.19).
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Fig. 2. The source of the data and format of the plots are similar to Figure 1, except that the data points denote equilibrated dialysis dose (eKt/V)
instead of SRI. The association of the dialysate/volume method with each of the other three methods is weaker than the associations among the
two blood-side methods and the dialysate curve-fit method (Table 3).
the three blood-side and dialysate curve-fit methods than errors in SRI determined from the blood-side methods
by comparing equations 11 and 12. This comparison isamong the three blood-side and dialysate curve-fit meth-
ods themselves. simplified by noting that because the blood samples from
a particular dialysis are typically processed and sent to-For both SRI and eKt/V, the median algebraic devia-
tion (median D) between the dialysate/volume method gether to the clinical laboratory and measured on the
same laboratory run, the measurement errors in C0, Ct,and the three blood-side and dialysate curve-fit methods
was relatively small and was not consistently larger than and C30 will usually be positively correlated. For quality-
control samples obtained during the HEMO Study (seethe median algebraic deviations among the blood-side
and dialysate curve-fit methods. This indicates that Procedures section), the correlation between errors in
C0 and Ct was 10.69, P , 0.001. Because the blood-the poorer agreement between the dialysate/volume
method and the other three methods reflects a greater based estimates of Ceq are directly correlated with Ct (for
the rate method) or C30 (for the observed 30-minutevariability rather than a systematic overestimation or
underestimation. postdialysis rebound method), it would be expected that
the correlation (r) between C0 and Ceq(blood) would be
Comparison of method reliability based on statistical positive. Assuming that r $ 0 and that eKt/V . 1.0, as
error analysis is the case for the HEMO Study, it can be shown from
Equations 11 and 12 that the CV for the error in SRIWe examined the conditions under which the magni-
tudes of the errors in SRI from the dialysate/volume using the volume method is greater than the CV of the
error in SRI using a blood-based method ifmethod can be expected to be larger or smaller than
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Table 3. Comparisons of equilibrated Kt/V (eKt/V) derived from different methods
Median Median Spearman Pearson Concordance
Methods compareda D |D| R R R
Blood-side rate equation vs. blood-side reference 20.034 0.061 0.89 0.88 0.87
Dialysate curve fit vs. blood-side reference 20.006 0.071 0.83 0.81 0.81
Dialysate curve fit vs. blood-side rate equation 20.031 0.078 0.88 0.88 0.87
Dialysate/volume vs. blood-side reference 10.012 0.169 0.59 0.47 0.43
Dialysate/volume vs. blood-side rate equation 10.033 0.147 0.61 0.49 0.42
Dialysate/volume vs. dialysate curve fit 10.029 0.178 0.49 0.41 0.37
Data were obtained from 128 Phase II and Phase III modeled dialyses.
a For each of the measures, median |D|, Spearman R, Pearson R, and Concordance R, the agreement among the three blood-side and dialysate curve fit methods
(top three rows) was significantly better (P , 0.05) than the agreement of the dialysate/volume method with each of the other three methods (bottom three rows).
Fig. 3. A simplified fixed volume model with
no urea generation showing the error mag-
nification caused by the dialysate/volume
method. A/V is the equivalent change in BUN
during dialysis calculated by dividing the
amount of urea nitrogen removed (A) by the
patient’s urea volume (V). This example
shows a 5% BUN measurement error in the
predialysis BUN that is expanded to 15% in
the final expression of eKt/V. In contrast to
direct measurement, when the equilibrated
postdialysis BUN (Ceq) is calculated by sub-
traction of A/V from C0, fractional errors in
the measured values are enlarged.
and blood-side methods is the dialysate/volume method’s
t2(A) .
1
2
· [t2(Ceq(blood))2t2(C0)2 2 · t2(Vm)] (Eq.14) use of the term C0 2 A/Vm in place of Ceq(blood). Thus, for
the dialysate/volume method, C0 2 A/Vm can be viewed
as estimating Ceq. A straightforward calculation showsExpression 14 indicates that even if we neglect errors
that an error of a% in C0 leads approximately to thein V and C0, A must be determined with a squared CV
same percentage error in Ceq(blood)/C0. On the other hand,of less than one half as great as the squared CV in Ceq(blood)
when Ceq is estimated by the difference between C0 andfor the precision of the dialysate/volume method to
A/V as in the dialysate/volume method, the error in thematch the precision of the blood-based methods. More-
estimated Ceq/C0 is approximately a · SRI/(1 2 SRI),over, any variability in the estimates of V or in C0 reduces
which is twice as large as the error in the blood-sidethe level of precision of the dialysate/volume method
approach when SRI is 0.667 and three times as largecompared with that of the blood-based methods. The
when SRI is 0.750. The larger error results from subtrac-ratio of the precision of the dialysate/volume method
tion of two relatively large numbers (C0 and A/V) toversus the blood-side methods is reduced further if the
produce a smaller number (Ceq). The same argumentcorrelation between the errors for C0 and Ceq(blood) is
indicates that errors in A/Vm also lead to proportionatelystrictly greater than zero, as will usually be the case.
greater percentage errors in the difference C0 2 A/Vm,
Illustrations of the effects of errors in C0 and in A/Vm indicating that the dialysate/volume method may be ex-
pected to amplify the effects of errors in A and Vm asOne implication of Equation 14 is that an error in C0
well as C0.leads to a greater error in eKt/V for the dialysate/volume
method than for a blood-based method. The explanation
Error analysis for eKt/Vfor this phenomenon is illustrated in Figure 3. Compari-
The factor SRI/[eKt/V(1 2 SRI)] relating the CV ofson of Equations 9 and 10 shows that the only difference
between the formulas for SRI for the dialysate/volume eKt/V to the CV of SRI in Equation 13 increases as the
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and dialysate curve-fit methods was markedly poorer
than the agreement among the alternative methods
themselves. This reasoning might be criticized on the
grounds that the strong agreement between the two
blood-side methods (r 5 10.88, median |D| 5 0.061 for
eKt/V) may reflect coupling of BUN measurement errors
so that the comparatively stronger agreement between
these two methods may not necessarily indicate a poorer
performance of the dialysate/volume method. However,
coupling of measurement errors cannot explain the
markedly better agreement of the blood-side and the
dialysate curve-fit methods (which were based on inde-
pendent measurements) with each other than with the
dialysate/volume method.
The statistical error analyses provided a second set of
evidence suggesting a poorer performance of the dialy-
sate/volume method. As shown in equation 14, even if
we neglect the error in Vm and C0, then for the precision
of the dialysate/volume method to match the precision
of a blood-based method, it would be necessary for the
squared CV of the urea removal (A) to be less than one
half of the squared CV of the estimate of Ceq in the
blood-based approach. Any variability in either C0 or inFig. 4. The coefficient of variation (CV) of eKt/V estimated from the
dialysate/volume method increases at high dialysis dose. The dashed Vm will add to the advantage of the blood-based methods
line indicates the CV of SRI computed by the dialysate/volume method relative to the dialysis/volume method. Thus, there ap-
as a function of the CV of the measurement error in the urea removal
pears to be an instability of the dialysate/volume method[t(A)]. The solid lines represent the CV of eKt/V computed by the
dialysate/volume method as a function of (tA; equation A-2). inherent in its mathematical definition, independent of
the precision with which urea removal is estimated.
One of the strengths of the dialysate/volume method
is its reliance on V. In contrast to clearance (K) and
dialysis dose increases, indicating that the variability of duration of treatment (Td), V is a physiological parame-
eKt/V becomes amplified relative to the variability of ter considered equivalent to the patient’s water volume
SRI for high dialysis doses, particularly as SRI ap- [29], which should vary little from month to month when
proaches its maximum limit of one. This reflects the measured at the end of dialysis. The known urea volume
defined limits of SRI within a narrow range bounded by (V) can be determined from measurements of the predi-
one at high doses of dialysis, as compared with eKt/V, alysis BUN (C0), the amount of urea removed during
which has no upper limit. Thus, although comparisons dialysis (A), and the equilibrated postdialysis BUN (Ceq;
of the performance of different methods in terms of eKt/ equation 1). Because V is relatively constant, compared
V will give similar results to comparisons of methods in with Ceq, eKt/V, and SRI, it can be repeatedly measured
terms of SRI, for all methods the variability of eKt/V and averaged over many dialysis treatments giving an
will be higher than the variability of SRI at high dialysis increasingly accurate figure expressed here as Vm. If Vm
doses. Figure 4, which describes Equation A2 of Appen- can be measured accurately, for example, as the mean
dix A, illustrates this point for the dialysate/volume of several measurements as was done in this study, the
method. equilibrated postdialysis BUN can be derived from it by
measuring A and C0 (equations 2 and 8). The effective
urea clearance or patient clearance can then be derived
DISCUSSION from single pool analysis of C0 and Ceq using urea kinetic
Despite the increased precision expected from integra- modeling.
tion of multiple measurements in the dialysate, the dialy- In principle, the dialysate/volume method would ap-
sate/volume method used in the HEMO Pilot Study ap- pear to have other advantages over the traditional fitting
pears to have given significantly less accurate measures of predialysis and postdialysis or multiple intradialysis
of eKt/V and SRI than either the blood-side techniques and postdialysis BUN measurements to a model of urea
or the dialysate curve-fit method. We base this conclu- kinetics. There are no constraints imposed by a mathe-
sion first on the finding that the agreement between the matical model, and once Vm is determined, there is no
need to measure the postdialysis BUN, sometimes calleddialysate/volume method and the alternative blood-side
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a “moving target.” The postdialysis BUN is subject to determination of dialysis prescriptions because it cannot
be directly related to a clearance, to blood and dialysateerror due to potential access recirculation, to the ever-
present rebound from dialysis disequilibrium, to dilution flow, or to treatment time like eKt/V.
with solutions often infused at the end of dialysis, and In conclusion, although the dialysate/volume method
to inaccuracies of measurement by clinical laboratories is attractive for other reasons, an empiric and theoretical
unaccustomed to measuring low concentrations with analysis of sensitivity showed that it caused much larger
high precision. In addition, even experienced technicians errors in measurement of both SRI and eKt/V than
will occasionally draw the postdialysis blood sample from blood-side methods. Consequently, the dialysate/volume
the wrong (venous return) port, falsely lowering the post- method had to be dropped from consideration for use
dialysis BUN and causing an overestimation of Kt/V. in the full scale HEMO Study. In general, methods for
Ideally, the postdialysis BUN should be measured at quantitating the dose of dialysis based on the change in
equilibrium, but this requires a delay of 30 to 60 minutes measured urea concentrations during dialysis (in blood
after stopping dialysis. Delaying each patient’s dialysis or in dialysate) appear to have an inherent advantage
on a repeated routine basis is not feasible in most dialysis in being more precise than methods that are limited to
centers. measurement of fractional urea removal.
However, as illustrated in Figure 3, a key difficulty
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APPENDIX A a function of a single random variable X1, then equation
By combining equations 13 and 11, we see that the B2 reduces to
CV for eKt/V based on the dialysate/volume method is
as follows:
Var[f(X1)] > 1 ]f]Xiu Xi5mi2
2
· s21
t(eKt/Vvol) >
SRI
eKt/V · (1 2 SRI)
3
To apply equations B1 and B2 to derive Equations
11, 12, and 13, the si are identified with variability due√t2(A) 1 t2(C0) 1 t2(Vm) (Eq. A1)
to measurement error, and the mi are regarded as the
“true values” of the respective quantities that wouldThis expression shows how the effects of errors in A,
have been obtained in the absence of measurement error.C0, and Vm on eKt/V are amplified at high doses of
dialysis. Based on the pilot study quality-control data, To avoid cumbersome notation, we will take advan-
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tage of the fact that the variability of the investigated
5 g(Ceq, C0) 5 1 2
Ceq
C0
. Thenquantities is small compared with their mean values and
take the liberty of writing C0, A, Vm, and Ceq in place
of the mean values of these quantities when applying ]g
]C0
5
Ceq
C20
,
]g
]Ceq
5 2
1
C0
, and
]g
]C0
·
]g
]Ceq
5 2
Ceq
C30
.Equations B1 and B2.
Derivation of equations 11 and 12 Equation B2 therefore implies
Let SRIVol 5 f(A, C0, Vm) 5 A/(C0 · Vm). Then,
Var(SRIblood) >
C 2eq
C40
· s2(C0) 1
1
C20
· s2(Ceq)
]f
]A
5
1
C0 · Vm
,
]f
]C0
5
2 A
C02 · Vm
,
2
2 · Ceq
C30
· s(C0) · s(Ceq) · r(C0, Ceq).
and
Equation 12 now follows by dividing both sides of this
expression by (C0 2 Ceq)2/C20 and taking the square root.]f
]Vm
5
2 A
C0 · V2m
.
Derivation of Equation 13
To obtain Equation 13, write eKt/V 5 2 ln(1 2 SRI)Because the measurement errors in A, C0, and Vm are
5 h(SRI), say. Thenstatistically independent and hence not correlated with
one another, Equation B2 gives:
]h
]SRI
5
1
1 2 SRI
,
Var (SRIVol) >
1
C20 · V2m
s2(A) 1
A2
C40 · V2m
· s2 (C0)
and by Equation B2,
1
A2
C20 · V4m
· s2(Vm)
Var(eKt/V) > 1
(1 2 SRI)2
· s2 (SRI).
5
A2
C 20 · V 2m
· [t2(A) 1 t2(C0) 1 t2(Vm)].
Hence,
Dividing both sides of this Equation by
A2
C20 · V2m
and tak- t2(eKt/V) > 1 SRI1 2 SRI2
2
· 1 1eKt/V2
2
· t2 (SRI),
ing the square root gives Equation 11.
To obtain Equation 12, write Ceq 5 Ceq(blood), and SRIblood from which Equation 13 follows.
